W celu świadczenia usług na najwyższym poziomie stosujemy pliki cookies. Korzystanie z naszej witryny oznacza, że będą one zamieszczane w Państwa urządzeniu. W każdym momencie można dokonać zmiany ustawień Państwa przeglądarki. Zobacz politykę Cookies

X

News

16 February, 2026

87. Collection of medical and cost data on services related to pregnancy and childbirth (JGP section N)

16 February, 2026

Guaranteed benefits covering diagnostic lump sums under oncology drug programs

10 February, 2026

Sign the document in the mObywatel app

17 December, 2025

CAPRICORD – invitation to patient organizations to cooperate

10 March, 2026

Recommendation of the President – Blenrep (belantamab mafodotin)

10 March, 2026

Announcement regarding the meeting of the Tariff Council on 26 February 2026

09 March, 2026

Communication of the meeting of Transparency Council No. 8/2026 on 23 February 2026 with resolutions

06 March, 2026

Publication AWA

06 March, 2026

Status of work in March

06 March, 2026

The Transparency Council meeting 11/2026 on 16 March 2026

06 March, 2026

Communication of the meeting of Transparency Council No. 9/2026 on 2 March 2026 with resolutions

05 March, 2026

Recommendation of the President – Beyonttra (akoramidis)

02 March, 2026

Recommendation of the President – Agamree (vamorol)

27 February, 2026

Publication AWA

27 February, 2026

The Transparency Council meeting 10/2026 on 9 March 2026

26 February, 2026

Recommendation of the President – Poltixa (apixaban)

24 February, 2026

Recommendation of the President – Tript-OH and Levotonine (L-5-hydroxytryptophan)

23 February, 2026

Recommendation of the President – Tyrvaya (varenicline)

23 February, 2026

The Transparency Council meeting 9/2026 on 2 March 2026

20 February, 2026

Publication AWA

20 February, 2026

Status of work in February

20 February, 2026

Recommendation of the President – Opdivo (nivolumab)

20 February, 2026

Recommendation of the President – Alyftrek (deutiwakaftor, tezakaftor, wanzakaftor)

20 February, 2026

Recommendation of the President – parathyroid biopsy

Home page

News Publications Publikacje BIP

#webinar agenda Aktualności announcement of the President azathioprinum Bimzelx Collegium AOTMiT colorectal cancer communication Communication from the Transparency Council Communication on the Tariff Council Cost Accounting Standard Council for Tariffs Affairs covering neonatal care cyclophosphamidum Data acquisition dental treatment services diseases of the organ of vision drug programme Empliciti entecavirum etanercept Fycompa gastroscopy glaucoma health policy program health policy programme health policy programme on breast cancer health policy programme on infertility treatment Health Policy Programmes Impavido in vitro Inovelon Jardiance Meeting of the Transparency Council methotrexatum Milupa Basic-P minimum wage increases mycophenolate mofetil new new tariffs news Notice Notice of the President Ontozry Onureg Opdivo Opdivo (nivolumab)opinion Opinion of the President Opinion of the Transparency Council Ospolot Ozurdex perinatal care Ponvory Position of the Transparency Council Press conference Recommendation Recommendation of the President Renastep report Rezurock sirolimus Suliqua Tariff Council Tariffs Council Tarification Plan 2025 tenofovirum disoproxilum the drug programme B.44 the drug programme B.82 The Meeting of the Tariffs Council trainings Transparency Council Tremfya update Vivitrol Yervoy

Pokaż więcej ↓

Pokaż mniej ↑